1
Clinical Trials associated with ChimeriVax-WN02Randomized, Double-blind, Placebo Controlled Phase II Trial of the Safety, Tolerability and Immunogenicity of Lyophilized ChimeriVax-WN02 West Nile Vaccine in Healthy Adults
The purpose of this study is to determine whether a single subcutaneous injection of ChimeriVax-WN02 vaccine is well tolerated, safe and induces protective antibodies against West Nile Disease. The study is divided into two parts; in the first part, a comparison of 3 dose levels of the vaccine will be made, with an inactive control. In the second part, the optimum dose level chosen after the first part will be given to older volunteers.
100 Clinical Results associated with ChimeriVax-WN02
100 Translational Medicine associated with ChimeriVax-WN02
100 Patents (Medical) associated with ChimeriVax-WN02
100 Deals associated with ChimeriVax-WN02